RU2004124041A - Препарат для заживления ран и предотвращения прилипания повязки к ране - Google Patents
Препарат для заживления ран и предотвращения прилипания повязки к ране Download PDFInfo
- Publication number
- RU2004124041A RU2004124041A RU2004124041/15A RU2004124041A RU2004124041A RU 2004124041 A RU2004124041 A RU 2004124041A RU 2004124041/15 A RU2004124041/15 A RU 2004124041/15A RU 2004124041 A RU2004124041 A RU 2004124041A RU 2004124041 A RU2004124041 A RU 2004124041A
- Authority
- RU
- Russia
- Prior art keywords
- salt
- concentration
- range
- band
- iodine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Surgery (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Claims (5)
1. Препарат для заживления ран и предотвращения прилипания повязки к ране, содержащий физиологически приемлемую соль гиалуроновой кислоты, имеющую молекулярный вес от 200000 до 2500000, йод и йодистый калий.
2. Препарат по п.1, отличающийся тем, что физиологически приемлемая соль гиалуроновой кислоты выбрана из группы, включающей натриевую соль, калиевую соль, литиевую соль, соль кальция, соль магния, соль цинка, соль кобальта и соль марганца или их сочетание.
3. Препарат по п.1, отличающийся тем, что концентрация физиологически приемлемой соли гиалуроновой кислоты находится в интервале от 0,05 до 10 вес.%, концентрация йода - в интервале от 0,05 до 2,5 вес.% и концентрация йодистого калия - в интервале от 0,05 до 5 вес.%
4. Препарат по п.3, отличающийся тем, что концентрация физиологически приемлемой соли гиалуроновой кислоты находится в интервале от 0,05 до 10 вес.%, концентрация йода - в интервале от 0,075 до 1 вес.% и концентрация йодистого калия - в интервале от 0,075 до 1 вес.%
5. Препарат по п.1, отличающийся тем, что он находится в виде стерильного водного раствора или геля.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ200212746U CZ12015U1 (cs) | 2002-01-18 | 2002-01-18 | Přípravek pro prevenci adheze bandáľe na ránu |
CZPUV02-12746 | 2002-01-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2004124041A true RU2004124041A (ru) | 2005-04-20 |
RU2296569C2 RU2296569C2 (ru) | 2007-04-10 |
Family
ID=5475977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2004124041/15A RU2296569C2 (ru) | 2002-01-18 | 2003-01-15 | Препарат для заживления ран и предотвращения прилипания повязки к ране |
Country Status (21)
Country | Link |
---|---|
US (1) | US20050181025A1 (ru) |
EP (1) | EP1487506B1 (ru) |
JP (1) | JP2005514445A (ru) |
KR (1) | KR100923122B1 (ru) |
CN (1) | CN1298394C (ru) |
AT (1) | ATE358501T1 (ru) |
AU (1) | AU2003206611B2 (ru) |
BR (1) | BR0302967A (ru) |
CA (1) | CA2470639C (ru) |
CZ (1) | CZ12015U1 (ru) |
DE (1) | DE60312969T2 (ru) |
DK (1) | DK1487506T3 (ru) |
ES (1) | ES2285092T3 (ru) |
HK (1) | HK1074011A1 (ru) |
IL (1) | IL162801A (ru) |
MX (1) | MXPA04006907A (ru) |
PT (1) | PT1487506E (ru) |
RU (1) | RU2296569C2 (ru) |
UA (1) | UA78264C2 (ru) |
WO (1) | WO2003059404A2 (ru) |
ZA (1) | ZA200404832B (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2308954C2 (ru) | 2002-05-09 | 2007-10-27 | Медиджинез | Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови |
US7323184B2 (en) * | 2005-08-22 | 2008-01-29 | Healagenics, Inc. | Compositions and methods for the treatment of wounds and the reduction of scar formation |
CN100355790C (zh) * | 2005-11-04 | 2007-12-19 | 山东福瑞达生物化工有限公司 | 一种透明质酸锌的制备方法 |
CN100348621C (zh) * | 2005-12-02 | 2007-11-14 | 凌沛学 | 透明质酸铋及其制备方法和应用 |
US20080241270A1 (en) * | 2007-03-30 | 2008-10-02 | Neal Robert A | Fluid composition for inhibiting surgical adhesion formation and related method of production |
CZ303471B6 (cs) * | 2007-10-03 | 2012-10-03 | Contipro Biotech S.R.O. | Prípravek pro hojení ran a prevenci adheze bandáže na ránu obsahující chitosan-glukan |
GB201004072D0 (en) * | 2010-03-11 | 2010-04-28 | Turzi Antoine | Process, tube and device for the preparation of wound healant composition |
CN102258800B (zh) * | 2010-05-25 | 2015-04-08 | 上海建华精细生物制品有限公司 | 一种复方创愈凝胶 |
CZ303548B6 (cs) * | 2011-01-05 | 2012-11-28 | Contipro Pharma A.S. | Zdravotní prípravek tvorící jód, zpusob jeho prípravy a bandáž, která jej obsahuje |
CA2950721C (en) | 2014-08-08 | 2020-05-12 | Nichi-Iko Pharmaceutical Co.,Ltd. | Jelly-like medicinal composition of potassium iodide |
CZ2017320A3 (cs) * | 2017-06-05 | 2019-01-16 | Contipro A.S. | Antimikrobiální kompozice obsahující polysacharid, stabilizátor a trijodid, způsob její přípravy a použití |
CN110997019A (zh) * | 2017-07-26 | 2020-04-10 | 优瑞株式会社 | 包含透明质酸-钙和聚赖氨酸的创伤覆料及其制造方法 |
CZ2018428A3 (cs) * | 2018-08-23 | 2019-12-04 | Contipro As | Kompozice obsahující jodid a derivát kyseliny hyaluronové s oxidačním účinkem, způsob její přípravy a použití |
CN111978600B (zh) * | 2020-09-02 | 2022-07-01 | 山东华熙海御生物医药有限公司 | 一种用于安抚奶嘴的透明质酸复合凝胶 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166331A (en) * | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
IT1212892B (it) * | 1983-10-11 | 1989-11-30 | Della Valle Francesco | Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica |
HU203372B (en) * | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
GB9514361D0 (en) * | 1995-07-13 | 1995-09-13 | Bristol Myers Squibb Co | A film for topical use in the treatment of wounds |
JP3748970B2 (ja) * | 1997-01-31 | 2006-02-22 | 電気化学工業株式会社 | ヒアルロン酸ナトリウム含有水溶液 |
JP3472442B2 (ja) * | 1997-06-05 | 2003-12-02 | 東亜薬品株式会社 | 損傷皮膚修復用製剤 |
EP0920875A1 (en) * | 1997-06-18 | 1999-06-09 | JAPAN as repr. by DIR. GENERAL of NATIONAL INST. OF SERICULTURAL & ENTOMOLOGICAL SCIENCE MINISTRY OF AGR, FORESTRY & FISHERI | Wound covering material containing silk fibroin and silk sericin as the main components and process for producing the same |
EP1005874B1 (en) * | 1997-08-22 | 2005-05-18 | Denki Kagaku Kogyo Kabushiki Kaisha | Hyaluronic acid gel, process for producing the same and medical material containing the same |
US6015836A (en) * | 1997-10-28 | 2000-01-18 | Martin; Howard | Chemical disinfectant employing dual chain quaternary ammonium compounds with iodine |
JP2000319171A (ja) * | 1999-03-03 | 2000-11-21 | Nof Corp | 殺菌性皮膚外用剤組成物 |
US20020037319A1 (en) * | 1999-11-08 | 2002-03-28 | Alan Drizen | Drug preparations |
CN1136012C (zh) * | 2000-08-07 | 2004-01-28 | 黄玲惠 | 伤口敷料及其制备方法 |
WO2003024373A1 (en) * | 2001-09-14 | 2003-03-27 | 3M Innovative Properties Company | Non-contact printing method for making a medical pressure sensitive adhesive article |
-
2002
- 2002-01-18 CZ CZ200212746U patent/CZ12015U1/cs not_active IP Right Cessation
-
2003
- 2003-01-15 MX MXPA04006907A patent/MXPA04006907A/es active IP Right Grant
- 2003-01-15 DK DK03704190T patent/DK1487506T3/da active
- 2003-01-15 CA CA002470639A patent/CA2470639C/en not_active Expired - Fee Related
- 2003-01-15 JP JP2003559564A patent/JP2005514445A/ja active Pending
- 2003-01-15 AT AT03704190T patent/ATE358501T1/de active
- 2003-01-15 KR KR1020047011002A patent/KR100923122B1/ko not_active IP Right Cessation
- 2003-01-15 IL IL162801A patent/IL162801A/en not_active IP Right Cessation
- 2003-01-15 CN CNB038022176A patent/CN1298394C/zh not_active Expired - Fee Related
- 2003-01-15 WO PCT/CZ2003/000003 patent/WO2003059404A2/en active IP Right Grant
- 2003-01-15 PT PT03704190T patent/PT1487506E/pt unknown
- 2003-01-15 DE DE60312969T patent/DE60312969T2/de not_active Expired - Lifetime
- 2003-01-15 US US10/501,887 patent/US20050181025A1/en not_active Abandoned
- 2003-01-15 AU AU2003206611A patent/AU2003206611B2/en not_active Ceased
- 2003-01-15 EP EP03704190A patent/EP1487506B1/en not_active Expired - Lifetime
- 2003-01-15 ES ES03704190T patent/ES2285092T3/es not_active Expired - Lifetime
- 2003-01-15 UA UA20040705873A patent/UA78264C2/uk unknown
- 2003-01-15 BR BR0302967-0A patent/BR0302967A/pt not_active IP Right Cessation
- 2003-01-15 RU RU2004124041/15A patent/RU2296569C2/ru not_active IP Right Cessation
-
2004
- 2004-06-18 ZA ZA200404832A patent/ZA200404832B/en unknown
-
2005
- 2005-06-22 HK HK05105224A patent/HK1074011A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20050181025A1 (en) | 2005-08-18 |
ES2285092T3 (es) | 2007-11-16 |
RU2296569C2 (ru) | 2007-04-10 |
EP1487506B1 (en) | 2007-04-04 |
CN1615159A (zh) | 2005-05-11 |
DE60312969T2 (de) | 2007-12-13 |
JP2005514445A (ja) | 2005-05-19 |
KR20040081128A (ko) | 2004-09-20 |
KR100923122B1 (ko) | 2009-10-23 |
CN1298394C (zh) | 2007-02-07 |
CZ12015U1 (cs) | 2002-02-25 |
AU2003206611B2 (en) | 2007-03-29 |
WO2003059404A2 (en) | 2003-07-24 |
IL162801A0 (en) | 2005-11-20 |
EP1487506A2 (en) | 2004-12-22 |
PT1487506E (pt) | 2007-07-13 |
UA78264C2 (en) | 2007-03-15 |
WO2003059404A3 (en) | 2004-03-18 |
CA2470639C (en) | 2009-12-22 |
HK1074011A1 (en) | 2005-10-28 |
CA2470639A1 (en) | 2003-07-24 |
BR0302967A (pt) | 2004-07-06 |
ATE358501T1 (de) | 2007-04-15 |
ZA200404832B (en) | 2005-07-27 |
AU2003206611A1 (en) | 2003-07-30 |
DE60312969D1 (de) | 2007-05-16 |
MXPA04006907A (es) | 2005-04-19 |
DK1487506T3 (da) | 2007-08-06 |
IL162801A (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2004124041A (ru) | Препарат для заживления ран и предотвращения прилипания повязки к ране | |
di Lena | Hemostatic polymers: the concept, state of the art and perspectives | |
JP6568519B2 (ja) | 医療用被覆器具 | |
AU2003251547B2 (en) | Physiologically balanced, ionized, acidic solution and methodology for use in wound healing | |
Mp | Local hemostatic agents in the management of bleeding in oral surgery | |
US20020176885A1 (en) | Physiologically balanced, ionized, acidic solution and methodology for use in wound healing | |
RU2010117016A (ru) | Хитозановая композиция | |
JPH08187280A (ja) | 創傷の手当てをするための無菌ゲル組成物およびゲルの製造方法 | |
CA2409076A1 (en) | Composition and method for growing, protecting, and healing tissues and cells | |
CN102335452A (zh) | 一种功能性敷料的配方与制备方法 | |
WO2014153238A9 (en) | Compositions, methods and devices for promoting wound healing and reducing infection | |
JPH1059851A (ja) | グアニジノ化合物低下剤並びに水分及びカリウムイオン吸着剤 | |
JP2015522632A5 (ru) | ||
RU2180856C1 (ru) | Средство для лечения ран | |
WO1996013284A1 (en) | Wound treatment composition | |
RU2582220C1 (ru) | Повязка для лечения ран на основе хитозана | |
RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных | |
RU2003118745A (ru) | Заживляющее средство | |
EP3585422A1 (en) | Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use | |
WO2017060821A1 (en) | Hemostatic composition | |
GB2392838A (en) | Calcium L-threonate for preventing or treating cartilage related diseases | |
KR101828434B1 (ko) | 갈산과 시아노아크릴레이트를 이용한 생체접착제 및 이의 제조방법 | |
JP2001017533A (ja) | 皮膚潰瘍補填修復材料 | |
RU2228758C1 (ru) | Способ мембранного диализа гнойно-воспалительных заболеваний | |
RU93057892A (ru) | ПОЛИ[(1-4)- α - L-ГУЛУРОНО-(1-4)- b -D-МАННУРОНАТ]КАЛЬЦИЙ-НАТРИЕВАЯ СОЛЬ - ИНГИБИТОР ВСАСЫВАНИЯ РАДИОНУКЛИДОВ И УСИЛИТЕЛЬ ЭЛИМИНАЦИИ ИХ ИЗ ОРГАНИЗМА |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD4A | Correction of name of patent owner | ||
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20170116 |